Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
DNA Repair|August 16, 2022
Roles of phosphatases in eukaryotic DNA replication initiation controlFiona Jenkinson, Philip ZegermanHospital Medicine (London, England : 1998)|August 28, 2004
Pleural effusions: the role of biochemical analysisFiona Jenkinson, Michael J MurphyAnnals of Clinical Biochemistry|September 1, 2007
Biochemical analysis of pleural and ascitic fluid: effect of sample timing on interpretation of resultsFiona Jenkinson, Michael J MurphyAnnals of Clinical Biochemistry|March 17, 2007
A rare case of metabolic bone diseaseRajeev Srivastava, Fiona Jenkinson, Michael J MurphyMolecular Cell|December 21, 2022
Dephosphorylation of the pre-initiation complex is critical for origin firingFiona Jenkinson, Kang Wei Tan, Barbara Schöpf, et al.British Journal of Cancer|March 24, 2020
Correction: A case of malignant hyperlactaemic acidosis appearing upon treatment with the mono-carboxylase transporter 1 inhibitor AZD3965Rosie McNeillis, Alastair Greystoke, Jon Walton, et al.British Journal of Cancer|February 21, 2020
A case of malignant hyperlactaemic acidosis appearing upon treatment with the mono-carboxylase transporter 1 inhibitor AZD3965Rosie McNeillis, Alastair Greystoke, Jon Walton, et al.Nutrients|September 5, 2019
Improved Eating Behaviour and Nutrient Intake in Noncompliant Patients with Phenylketonuria after Reintroducing a Protein Substitute: Observations from a Multicentre StudyBenjamin Green, Yusof Rahman, Sarah Firman, et al.Atherosclerosis|May 30, 2023
Long-term effects of volanesorsen on triglycerides and pancreatitis in patients with familial chylomicronaemia syndrome (FCS) in the UK Early Access to Medicines Scheme (EAMS)Alan Jones, Katherine Peers, Anthony S Wierzbicki, et al.Metabolites|May 26, 2023
Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome-Causes, Clinical Presentation, and Therapeutic OptionsBilal Bashir, Jan H Ho, Paul Downie, et al.Pageof 2